AKBA - Akebia Therapeutics, Inc.
1.25
0.030 2.400%
Share volume: 1,916,150
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.22
0.03
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-10-2025 | 02-26-2026 | |
| Total revenue | 32.607 M | 43.648 M | 37.428 M | 46.497 M | 57.336 M | 62.472 M | 58.766 M | 57.622 M | |
| Cost of revenue | 11.605 M | 17.047 M | 14.161 M | 20.364 M | 7.625 M | 9.919 M | 9.383 M | 12.535 M | |
| Gross profit | 21.002 M | 26.601 M | 23.267 M | 26.133 M | 49.711 M | 52.553 M | 49.383 M | 45.087 M | |
| 26.66% | -12.53% | 12.32% | 90.22% | 5.72% | -6.03% | -8.70% | |||
| Operating expenses | 35.169 M | 34.564 M | 35.003 M | 39.461 M | 35.496 M | 37.568 M | 44.038 M | 52.737 M | |
| Selling general and admin | 25.438 M | 26.917 M | 26.516 M | 27.674 M | 25.742 M | 26.555 M | 29.094 M | 26.089 M | |
| Research and development | 9.731 M | 7.647 M | 8.487 M | 11.787 M | 9.754 M | 11.013 M | 14.944 M | 26.648 M | |
| Total expenses | 35.938 M | 35.326 M | 35.772 M | 40.439 M | 36.197 M | 38.464 M | 44.934 M | 53.640 M | |
| -1.70% | 1.26% | 13.05% | -10.49% | 6.26% | 16.82% | 19.38% | |||
| Operating income | -14.936 M | -8.725 M | -12.505 M | -14.306 M | 13.514 M | 14.089 M | 4.449 M | -8.553 M | |
| Ebit | -14.970 M | -6.433 M | -13.378 M | -15.927 M | 13.882 M | 7.081 M | 5.903 M | -6.408 M | |
| Pretax income | -17.985 M | -8.582 M | -20.039 M | -22.804 M | 6.112 M | 247.000 K | 1.155 M | -11.235 M | |
| -52.28% | 133.50% | 13.80% | -126.80% | -95.96% | 367.61% | -1,072.73% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 615.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -17.985 M | -8.582 M | -20.039 M | -22.804 M | 6.112 M | 247.000 K | 540.000 K | -12.244 M | |
| 52.28% | -133.50% | -13.80% | 126.80% | -95.96% | 118.62% | -2,367.41% |